ISSCA Announces Partnership with Turkish Stem Cell Society and Endorsement by Leading Turkish Universities for Regenerative Medicine Congress
Miami, Florida – The International Society for Stem Cell Application (ISSCA) is delighted to announce its strategic partnership with the Turkish Stem Cell Society, along with the prestigious endorsement of three of Turkey’s top universities: Yeditepe University, Atlas University and Marmara University. This collaboration marks a significant milestone in advancing the field of regenerative medicine and stem cell therapy in Turkey and beyond.
The annual Congress of Regenerative Medicine, scheduled to take place from November 10 to 12, 2023, will be hosted at the elegant Crowne Plaza Istanbul Florya Hotel in Istanbul, Turkey. This event is poised to serve as a pivotal platform for the exchange of groundbreaking advancements in stem cell therapy and regenerative medicine.
Partnership with Turkish Stem Cell Society and University Endorsements
The partnership with the Turkish Stem Cell Society underscores the commitment of ISSCA to advancing the field of regenerative medicine not only on a global scale but also within the vibrant Turkish scientific and medical community. Turkish Stem Cell Society has been at the forefront of research and innovation in stem cell therapy, making this collaboration a natural fit to foster greater knowledge sharing and cooperation.
Furthermore, ISSCA is honored to be endorsed by three of the most prestigious universities in Turkey:
Yeditepe University: Yeditepe University, a leading academic institution in Turkey, has a rich history of contributing to the fields of medicine and healthcare. Its endorsement of the Regenerative Medicine World Congress 2023 reaffirms the importance of this event in advancing the understanding of regenerative medicine.
Atlas University: Atlas University, with its commitment to research and innovation, plays a pivotal role in shaping the future of healthcare in Turkey. The university’s endorsement signifies the importance of regenerative medicine in modern medical practices.
Marmara University: Marmara University, recognized for its commitment to excellence in education, research, and innovation, is yet another prestigious institution supporting the congress. With a strong emphasis on interdisciplinary collaboration and cutting-edge research, Marmara University has become a center of intellectual discovery and academic achievement. The university’s renowned faculty and state-of-the-art infrastructure collaborate with Global Stem Cells Group to drive advances in regenerative medicine within the center, which is located on the university’s main campus.
World Congress Highlights
Representing over 35 countries, the Regenerative Medicine World Congress 2023 is set to be a hub of medical expertise. Renowned doctors and scientists from around the globe are expected to converge to share their insights and findings through evidence-based research presentations. This three-day symposium is designed to reshape medical understanding and ignite innovative possibilities.
A key feature of the congress is the immersive hands-on training, provided by ISSCA-certified instructors. Participants are expected to have the opportunity to delve into clinical and aesthetic applications of stem cell therapy over a single intensive day. This specialized training, guided by experts with extensive experience, equips attendees with practical skills that can be directly applied in their medical practice.
Collaboration and Appreciation
ISSCA is thrilled about the collaborative partnership with the Turkish Stem Cell Society and deeply appreciates the endorsements from Yeditepe University, Atlas University, and Marmara University. We look forward to the Regenerative Medicine World Congress 2023 as a significant step towards advancing the field of regenerative medicine. Your support and participation are invaluable, and we are genuinely excited to embark on this journey together.
For more information about the Regenerative Medicine World Congress 2023 and to register for this groundbreaking event, please visit www.issca.com
About the Turkish Stem Cell Society:
The Turkish Stem Cell Society is a leading organization dedicated to promoting ethical and responsible stem cell research and therapy in Turkey. They are committed to advancing scientific knowledge and education in the field of stem cells and regenerative medicine.
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians who aspire to treat diseases and lessen human suffering through advances in science, technology, and the practice of regenerative medicine. ISSCA serves its members through advancements made in the specialty of regenerative medicine.
The mission of ISSCA is to establish itself as a global leader in regenerative medicine certification, education, research, and training.
ISSCA provides certification training in cities worldwide because it recognizes the importance of standards and certifications in regenerative medicine as a medical specialty. To help more people, both locally and globally, as the demand for more doctors interested in and comfortable with regenerative medicine surges. ISSCA’s mission is to advance quality and uniformity in regenerative medicine worldwide.
About Global Stem Cells Group:
The Global Stem Cell Group is a family of several companies focused on stem cell medicine and research. The company uses its network to bring leadership in regenerative medicine training, research, and patient applications.
GSCG’s mission is to allow physicians to present the benefits of stem cell medicine to patients worldwide. The company also partners with policymakers, educators, and regulators to promote regenerative medicine.
Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. https://finance.yahoo.com/quote/mssv/
To learn more about Global Stem Cells Group, Inc.’s companies visit our website www.stemcellsgroup.com or call +1 305 560 5331
Safe Harbor Statement:
Statements in this news release may be “forward-looking statements”. Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions, or any other information relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates, and projections about our business based partly on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual outcomes and results may and are likely to differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release, and The Global Stem Cells Group undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release. This press release does not constitute a public offer of any securities for sale. Any securities offered privately will not be or have not been registered under the Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.